News about patents
New products and ideas are born every day. Technology is developing very fast in all sectors. Look at the rapid developments in the market for mobile phone devices or at the advances in the field of healthcare, for example, or the enormous investments and developments in biotechnology and the new focus on sustainability in the motor industry. Not only are these interesting developments to follow, but also they are increasingly being accompanied by a discussion about the ownership of patents in general. These are all things that concern us and which we would like to share with you. For the latest news stories, see below.
IP and R&D: should you search before research?
IP strategy is best considered at the start of research and development (R&D). The first step is choosing the IP approach to take during product development. Novagraaf’s Mark Suddaby explains the options.
Pharmaceuticals: ingenious, but is it patentable?
In the final of our reports from the AIPPI Annual Congress that took place in Milan in September, we look at IP issues currently facing the pharmaceutical sector. This was an industry much discussed at the event from the possible implications for Supplementary Protection Certificates (SPCs) in the UK post-Brexit to new regulations on ‘skinny labels’. Below is an overview of the points..
IP transactions: Managing unregistered or associated IP rights
Few IP ownership transfers solely concern registered IP rights. Unregistered rights and other forms of intangible assets also play a crucial role in mergers and acquisitions (M&A), and other forms of IP transactions. We set out the process for managing the transfer of such rights.
Brexit – the uncertainty continues
The AIPPI conference in Milan earlier this month added a last-minute session on Brexit following the UK’s vote to leave the EU. The room was packed for the discussion, but what did the panellists think would be the IP implications of the historical vote?
Trademark event: meet us at the 2016 PTMG Autumn Conference
Trademark experts from Novagraaf will be attending the Autumn Conference of the Pharmaceutical Trade Marks Group (PTMG) in Oslo, Norway from 5-8 October. If you’re attending, why not get in touch to set up a time to meet?
IP event: Join us at the 2016 AIPPI World Congress in Milan
Visit us at booth #37 at this year's annual meeting of the International Association for the Protection of Intellectual Property (AIPPI) in Milan, Italy on 16-20 September.
IP transactions: Recording a change of ownership
In the first part of our in-depth look at the IP assignment process, we set out best practice advice and procedures for smoothing the transition from sales agreement to completion. This time, Novagraaf’s Tom Farrand sets out recommended preparations for recording the change of ownership of registered rights.
Changes to terms of reimbursement for EP examination fees
The European Patent Office (EPO) has changed the terms of reimbursement for European Patent (EP) examination fees. Novagraaf’s Philippe Vigand outlines the changes.
IP ownership transfers: Getting your IP rights in order
Intangible assets typically make up more than 50% of the value of a modern business. In some sectors (for example, pharmaceuticals), that percentage is much higher. In general, IP forms the greater part of these assets; it is hardly surprising that purchasers of businesses and their assets should pay careful attention to the process of perfecting ownership of IP rights.
Brexit – what does it mean for your IP rights?
It was predicted to be a close result, yet the British public's vote to 'Brexit' the European Union in yesterday's referendum will still have come as an unwelcome shock to many. It has also led to considerable uncertainty. This will be the first time that a significant member of the EU has left, and there is no detailed mechanism in place yet to structure that exit. What will it mean for IP..